mirtazapine has been researched along with mdl 100907 in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Bhagwagar, Z; Cowen, PJ; Cunningham, VJ; Grasby, PM; Hinz, R | 1 |
| Alfinito, PD; Cosmi, S; Deecher, DC; Maswood, N; Pawlyk, AC | 1 |
| Carley, DW; Olopade, C; Radulovacki, M; Ruigt, GS | 1 |
| Ceccherini-Nelli, L; Focosi, D; Kast, RE; Lauria, G; Maggi, F; Petrini, M | 1 |
| Bhagwagar, Z; Cowen, PJ; Cunningham, VJ; Grasby, PM; Hinz, R; Meyer, PT | 1 |
| Poyurovsky, M | 1 |
| Iwamura, T; Kasai, M; Kato, S; Nisijima, K; Shioda, K; Yoshino, T | 1 |
| Atzori, C; Bonora, S; Busolli, P; Calcagno, A; Ghisetti, V; Imperiale, D; Trentalange, A | 1 |
| El-Tanbouly, DM; Sayed, RH; Wadie, W | 1 |
| Poyurovsky, M; Weizman, A | 1 |
| Aoyama, T; Katsuyama, M; Kawano, Y; Mano, Y; Mori, A; Nagata, M; Nakamatsu, S; Negishi, K; Obana, M; Sakamoto, N; Shimada, S | 1 |
1 trial(s) available for mirtazapine and mdl 100907
| Article | Year |
|---|---|
Efficacy of mirtazapine in obstructive sleep apnea syndrome.
Topics: Administration, Oral; Adolescent; Adult; Aged; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Polysomnography; Serotonin 5-HT2 Receptor Antagonists; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Sleep Apnea, Obstructive | 2007 |
10 other study(ies) available for mirtazapine and mdl 100907
| Article | Year |
|---|---|
Validation of a tracer kinetic model for the quantification of 5-HT(2A) receptors in human brain with [(11)C]MDL 100,907.
Topics: Adult; Antidepressive Agents; Brain; Brain Chemistry; Carbon Radioisotopes; Chromatography, High Pressure Liquid; Data Interpretation, Statistical; Female; Fluorobenzenes; Humans; Image Processing, Computer-Assisted; Kinetics; Magnetic Resonance Imaging; Male; Mianserin; Middle Aged; Mirtazapine; Models, Neurological; Models, Statistical; Piperidines; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, Serotonin, 5-HT2A; Reproducibility of Results; Serotonin Antagonists; Spectrophotometry, Ultraviolet | 2007 |
Effects of the 5-HT2A antagonist mirtazapine in rat models of thermoregulation.
Topics: Animals; Body Temperature Regulation; Dose-Response Relationship, Drug; Female; Hot Flashes; Mianserin; Mirtazapine; Ovariectomy; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists | 2006 |
5-HT2a inhibitors for progressive multifocal leukoencephalopathy: old drugs for an old disease.
Topics: Adult; Female; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Male; Mianserin; Middle Aged; Mirtazapine; Polycythemia Vera; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Antagonists | 2008 |
Simplified quantification of 5-HT2A receptors in the human brain with [11C]MDL 100,907 PET and non-invasive kinetic analyses.
Topics: Adult; Brain; Brain Mapping; Carbon Radioisotopes; Female; Fluorobenzenes; Humans; Kinetics; Linear Models; Male; Mianserin; Middle Aged; Mirtazapine; Models, Neurological; Piperidines; Positron-Emission Tomography; Receptor, Serotonin, 5-HT2A; Serotonin Agents; Signal Processing, Computer-Assisted | 2010 |
Acute antipsychotic-induced akathisia revisited.
Topics: Acute Disease; Akathisia, Drug-Induced; Antipsychotic Agents; Humans; Mianserin; Mirtazapine; Practice Guidelines as Topic; Serotonin 5-HT2 Receptor Antagonists | 2010 |
The effects of mirtazapine and fluoxetine on hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats.
Topics: Animals; Antidepressive Agents, Tricyclic; Disease Models, Animal; Fever; Fluoxetine; Male; Mianserin; Mirtazapine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Wistar; Serotonin 5-HT2 Receptor Antagonists; Serotonin Agents | 2011 |
Clearance of cerebrospinal fluid JCV DNA with mirtazapine in a patient with progressive multifocal leukoencephalopathy and sarcoidosis.
Topics: Aged; DNA, Viral; Female; Humans; Immunosuppressive Agents; JC Virus; Leukoencephalopathy, Progressive Multifocal; Mianserin; Mirtazapine; Sarcoidosis; Serotonin 5-HT2 Receptor Antagonists | 2016 |
Modulation of TGF-β/Smad and ERK signaling pathways mediates the anti-fibrotic effect of mirtazapine in mice.
Topics: Animals; Antioxidants; Collagen; Glutathione; Hepatic Stellate Cells; Hypertension, Portal; Lipid Peroxidation; Liver; Liver Cirrhosis, Experimental; Male; Mianserin; Mice; Mirtazapine; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; NADH, NADPH Oxidoreductases; NADPH Oxidase 1; Oxidative Stress; Phosphorylation; Protein Kinase C; Receptor, Serotonin, 5-HT2A; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Signal Transduction; Smad3 Protein; Thioacetamide; Transforming Growth Factor beta1 | 2017 |
Very Low-Dose Mirtazapine (7.5 mg) in Treatment of Acute Antipsychotic-Associated Akathisia.
Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Female; Humans; Male; Mental Disorders; Middle Aged; Mirtazapine; Off-Label Use; Outcome Assessment, Health Care; Serotonin 5-HT2 Receptor Antagonists; Young Adult | 2018 |
Antiplatelet Effect of Mirtazapine via Co-blocking of the 5-HT
Topics: Administration, Oral; Adrenergic alpha-2 Receptor Antagonists; Animals; Blood Platelets; Epinephrine; Male; Mice; Mirtazapine; Models, Animal; Platelet Aggregation; Receptor, Serotonin, 5-HT2A; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Succinates; Yohimbine | 2021 |